173 related articles for article (PubMed ID: 8180375)
1. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells.
Lyman SD; James L; Johnson L; Brasel K; de Vries P; Escobar SS; Downey H; Splett RR; Beckmann MP; McKenna HJ
Blood; 1994 May; 83(10):2795-801. PubMed ID: 8180375
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.
Lyman SD; James L; Vanden Bos T; de Vries P; Brasel K; Gliniak B; Hollingsworth LT; Picha KS; McKenna HJ; Splett RR
Cell; 1993 Dec; 75(6):1157-67. PubMed ID: 7505204
[TBL] [Abstract][Full Text] [Related]
3. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
[TBL] [Abstract][Full Text] [Related]
4. Expression of the flt3 receptor and its ligand on hematopoietic cells.
Brasel K; Escobar S; Anderberg R; de Vries P; Gruss HJ; Lyman SD
Leukemia; 1995 Jul; 9(7):1212-8. PubMed ID: 7630197
[TBL] [Abstract][Full Text] [Related]
5. Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells.
McKenna HJ; de Vries P; Brasel K; Lyman SD; Williams DE
Blood; 1995 Nov; 86(9):3413-20. PubMed ID: 7579445
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of human and murine flt3 ligand genomic loci.
Lyman SD; Stocking K; Davison B; Fletcher F; Johnson L; Escobar S
Oncogene; 1995 Sep; 11(6):1165-72. PubMed ID: 7566977
[TBL] [Abstract][Full Text] [Related]
7. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
Rossner MT; McArthur GA; Allen JD; Metcalf D
Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
[TBL] [Abstract][Full Text] [Related]
8. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.
Hannum C; Culpepper J; Campbell D; McClanahan T; Zurawski S; Bazan JF; Kastelein R; Hudak S; Wagner J; Mattson J
Nature; 1994 Apr; 368(6472):643-8. PubMed ID: 8145851
[TBL] [Abstract][Full Text] [Related]
9. Biology of flt3 ligand and receptor.
Lyman SD
Int J Hematol; 1995 Aug; 62(2):63-73. PubMed ID: 8590775
[TBL] [Abstract][Full Text] [Related]
10. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
Lyman SD; Brasel K; Rousseau AM; Williams DE
Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
[TBL] [Abstract][Full Text] [Related]
11. Expression and physiologic significance of Kit ligand and stem cell tyrosine kinase-1 receptor ligand in normal human CD34+, c-Kit+ marrow cells.
Ratajczak MZ; Kuczynski WI; Sokol DL; Moore JS; Pletcher CH; Gewirtz AM
Blood; 1995 Sep; 86(6):2161-7. PubMed ID: 7545021
[TBL] [Abstract][Full Text] [Related]
12. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
13. The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors.
Jacobsen SE; Okkenhaug C; Myklebust J; Veiby OP; Lyman SD
J Exp Med; 1995 Apr; 181(4):1357-63. PubMed ID: 7535335
[TBL] [Abstract][Full Text] [Related]
14. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
[TBL] [Abstract][Full Text] [Related]
15. Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct.
Gotze KS; Ramirez M; Tabor K; Small D; Matthews W; Civin CI
Blood; 1998 Mar; 91(6):1947-58. PubMed ID: 9490677
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
Casteran N; Rottapel R; Beslu N; Lecocq E; Birnbaum D; Dubreuil P
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):443-56. PubMed ID: 7920189
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha.
Ramsfjell V; Borge OJ; Cui L; Jacobsen SE
J Immunol; 1997 Jun; 158(11):5169-77. PubMed ID: 9164933
[TBL] [Abstract][Full Text] [Related]
18. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha.
Jacobsen SE; Veiby OP; Myklebust J; Okkenhaug C; Lyman SD
Blood; 1996 Jun; 87(12):5016-26. PubMed ID: 8652814
[TBL] [Abstract][Full Text] [Related]
19. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation.
Rasko JE; Metcalf D; Rossner MT; Begley CG; Nicola NA
Leukemia; 1995 Dec; 9(12):2058-66. PubMed ID: 8609717
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional effect of interleukin-10 on early murine B-cell development: stimulation of flt3-ligand plus interleukin-7-dependent generation of CD19(-) ProB cells from uncommitted bone marrow progenitor cells and growth inhibition of CD19(+) ProB cells.
Veiby OP; Borge OJ; Mârtensson A; Beck EX; Schade AE; Grzegorzewski K; Lyman SD; Mârtensson IL; Jacobsen SE
Blood; 1997 Dec; 90(11):4321-31. PubMed ID: 9373243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]